GLP-1
Clinical trials for GLP-1 explained in plain language.
Never miss a new study
Get alerted when new GLP-1 trials appear
Sign up with your email to follow new studies for GLP-1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Weight-Loss drug users get vitamin check in new study
Disease control ENROLLING_BY_INVITATIONThis study looks at whether taking a daily multivitamin can prevent vitamin and mineral deficiencies in people using GLP-1 weight-loss drugs like tirzepatide. About 246 adults who have been on these drugs for at least 3 months will either receive a multivitamin or a placebo for 1…
Matched conditions: GLP-1
Phase: NA • Sponsor: Erasmus Medical Center • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
Plant-Based supplement aims to curb appetite naturally
Symptom relief OngoingThis study tests whether a dietary supplement made from plant extracts can help control appetite and feelings of fullness in adults who are overweight or obese. Over 12 weeks, 40 participants will take either the supplement or a placebo, and researchers will measure gut hormones …
Matched conditions: GLP-1
Phase: NA • Sponsor: FFoQSI - Austrian Competence Centre for Feed and Food Quality, Safety & Innovation • Aim: Symptom relief
Last updated May 19, 2026 11:48 UTC
-
Diabetes drug eye risk under microscope
Knowledge-focused OngoingThis study looks at how newer diabetes medications (SGLT2 inhibitors and GLP-1 receptor agonists) affect the eyes of people with type 2 diabetes. Researchers will monitor 40 adults who take metformin and are starting these newer drugs. The goal is to see if these drugs cause any …
Matched conditions: GLP-1
Sponsor: University of Athens • Aim: Knowledge-focused
Last updated May 26, 2026 03:54 UTC